Drug-induced linear IgA disease with antibodies to collagen VII

British Journal of Dermatology

Volumn 138, Issue 2, 1998, Pages 310-314

  Wakelin, S H ^a,b   Allen, J ^a   Zhou, S ^a   Wojnarowska, F ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 7; IMMUNOGLOBULIN A; PENICILLIN G;

AGED; ANTIGEN RECOGNITION; ARTICLE; BASEMENT MEMBRANE; BULLOUS SKIN DISEASE; CASE REPORT; HUMAN; IMMUNOGLOBULIN DEPOSITION; MALE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION;

AGED; ANTIBODIES; BASEMENT MEMBRANE; COLLAGEN; DRUG ADMINISTRATION SCHEDULE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN A; INFUSIONS, INTRAVENOUS; MALE; PENICILLIN G; PNEUMOCOCCAL INFECTIONS; SKIN DISEASES, VESICULOBULLOUS;

EID: 0031917221     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02081.x     Document Type: Article

References (40)

1. Collier P, Wojnarowska F. MHC class I and II antigens in linear IgA dermatosis. J Invest Dermatol 1992; 98: 526 (Abstr.).
2. Keuchle MK, Stegemeir K, Maynard B et al. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol 1994; 30: 187-92.
3. Collier PM, Wojnarowska E Drug-induced linear immunoglobulin A disease. Clin Dermatol 1995; 11: 529-33.
4. Paul C, Wolkenstein P, Prost C et al. Drug-induced linear IgA disease: target antigens are heterogeneous. Br J Dermatol 1997; 136: 406-11.
5. Wojnarowska F, Marsden RA, Bhogal B, Black MM. Chronic bullous disease of childhood, childhood cicatricial pemphigoid and linear IgA disease of adults: a comparative study demonstrating clinical and immunological overlap. J Am Acad Dermatol 1988; 19: 792-805.
6. Godfrey K, Wojnarowska F, Leonard J. Linear IgA disease of adults: association with lymphoproliferative malignancy and possible role of other triggering factors. Br J Dermatol 1991; 123: 447-52.
7. Tatnall FM, Whitehead PC, Black MM et al. Identification of the epidermolysis bullosa acquisita antigen by LH 7.2 monoclonal antibody: use in diagnosis. Br J Dermatol 1989; 120: 533-9.
8. Zhou S, Fergusson DPJ, Allen J, Wojnarowska F. The localisation of binding sites of pemphigus vulgaris and pemphigus foliaceus autoantibodies: a post-embedding immunoelectron microscopy study. Br J Dermatol 1997; 136: 878-83.
9. Argenyi ZB, Bergfeld WK, Valenzuela R et al. Adult linear IgA disease associated with an erythema multiforme-like drug reaction. Cleve Clin J Med 1987; 54: 445-50.
10. Baden LA, Apovian C, Imber MJ et al. Vancomycin-induced linear IgA bullous dermatosis (letter). Arch Dermatol 1988; 124: 1186-8.
11. Bitman LM, Grossman ME, Ross H. Bullous drug eruption treated with amputation. Arch Dermatol 1996; 132: 1289-90.
12. Carpenter S, Berg D, Sidhu-Malik N et al. Vancomycin-associated linear IgA dermatosis. J Am Acad Dermatol 1992; 26: 45-8.
13. Combemale P, Gavaud C, Cozzani E et al. Dermatose à IgA lineaire (DIAL) induite par penicilline G. Ann Dermatol Venereol 1993; 120: 847-8.
14. Espagne E, Prost C, Chosidow O et al. Dermatoses à IgA lineaire medicamenteuses. Ann Dermatol Venerol 1990; 117: 898-9.
15. Gabrielsen TO, Staerfelt F, Thune PO. Drug-induced bullous dermatosis with linear IgA deposits along the basement membrane. Acta Derm Venereol (Stockh) 1981; 61: 439-41.
16. Geissmann C, Beylot-Barry M, Doutre MS, Beylot C. Drug-induced linear IgA bullous dermatosis (letter: comment). J Am Acad Dermatol 1995; 32: 296.
17. Guillaume J-C, Escidoer B, Espagne E et al. Dermatose bulleuse avec dépôts lineaires d'IgA-le long de la membrane basale au cours d'un traitement per l'interferon gamma et l'interleukine-2. Ann Dermatol Venerol 1990; 117: 899-902.
18. Klein LE, Shumunes E, Carter JB et al. Linear IgA bullous dermatosis related to captopril treatment. Cutis 1989; 44: 395-6.
19. Lemarchand-Venencie F, Vigouroux F, Blanc F et al. Dermatose bulleuse à IgA lineaire au decours immediat d'une urographie intra-veineuse. Ann Dermatol Venereol 1987; 114: 1423-5.
20. McWhirter JD, Hashimoto K, Fayne S et al. Linear IgA bullous dermatosis related to lithium carbonate (letter). Arch Dermatol 1987; 123: 1120-2.
21. Picketty C, Meeus F, Nochy D et al. Linear IgA dermatosis related to vancomycin. Br J Dermatol 1994; 130: 130-1.
22. Primka EJ, Liranzo MO, Bergfield WF, Dijkstra JW. Amiodarone-induced linear IgA disease. J Am Acad Dermatol 1994; 31: 809-11.
23. Vaatainen N, Fraki JE, Hyvonen M, Neittaanmaki H. Purpura with a linear epidermo-dermal deposition of IgA. Acta Derm Venereol (Stockh) 1983; 63: 169-70.
24. Valsecchi R, Serra M, Tornaghi A et al. Dermatosi bullosa da farmaco a IgA lineari. G Ital Dermatol Venereol 1982; 117; 221-3.
25. Whitworth JM. Thomas I, Peltz SA et al. Vancomycin-induced linear IgA bullous dermatosis. J Am Acad Dermatol 1996; 34: 890-1.
26. Tranvan A, Pezen DS, Medenica M et al. Interleukin-2 associated linear IgA bullous dermatosis. J Am Acad Dermatol 1996; 35: 865-7.
27. Boffety B, Sohier J, Venencie PY et al. Dermatoses bulleuses à IgA lineaire. In: Journéès Dermatologiques de Paris. Paris: Société Française de Dermatologie et Vénéréé, 1981; 53.
28. Wojnarowska F, Collier PM, Allen J, Millard PM. The localization of the target antigens in linear IgA disease is heterogeneous, and dependent on the methods used. Br J Dermatol 1995; 132: 750-7.
29. Ishiko A, Shimizu H, Masunaga T et al. 97-kDa linear IgA bullous dermatosis (LAD) antigen localizes to the lamina lucida of the epidermal basement membrane. J Invest Dermatol 1996; 106: 739-43.
30. Marinkovich MP, Taylor TB, Keene DR et al. Linear IgA disease autoantigen is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 1996; 106: 734-8.
31. Kanitakis J, Mauduit G, Cozzani E et al. Linear IgA bullous dermatosis of childhood with antoantibodies to a 230kDa epidermal antigen. Pediatr Dermatol 1994; 11: 139-44.
32. Gohestani R, Cozzani E, Nicolas JF et al. Linear IgA bullous dermatosis with IgA antoantibodies exclusively to BPAG1 and PBAG2. J Invest Dermatol 1996; 106: 846 (Abstr.).
33. Zone JJ, Taylor TB, Meyer LJ, Petersen MJ. The 97-kDa linear IgA hullous disease antigen is a portion of the extracellular domain of the 180kDa bullous pemphigoid antigen. J Invest Dermatol 1997; 108: 563 (Abstr.).
34. Wojnarowska F, Whitehead P, Leigh IM et al. Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults. Br J Dermatol 1991; 124: 157-62.
35. Dmochowski M, Hashimoto T, Bhogal BS et al. Immunoblotting studies of linear IgA disease. J Dermatol Sci 1993; 6: 194-200.
36. Rusenko KW, Gammon WR, Briggaman RA. Type VII collagen is the antigen recognised by IgA anti-sublamina densa antibodies. J Invest Dermatol 1989; 92: 510 (Abstr.).
37. Zambruno G, Manca V, Kanitakis J et al. Linear IgA bullous dermatosis with autoantibodies to a 290 kDa antigen of anchoring fibrils. J Am Acad Dermatol 1994; 31: 884-8.
38. Hashimoto T, Ishiko A, Shimizu H et al. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen antibodies. Br J Dermatol 1996; 134: 336-9.
39. Woodley DT, Burgeson RE, Lunstrom G et al. The epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988; 81: 685-7.
40. Allen J, Zhou S, Wakelin SH, Collier P, Wojnarowska F. Linear IgA disease: a report of two dermal binding sera which recognize a pepsin-sensitive epitope (?NC-1 domain) of collagen type VII. Br J Dermatol 1997; 137: 526-33.